TM6SF2 was demonstrated to localize in the ER, and knocking down TM6SF2 in human HCC cells resulted in a decrease in the levels of TG synthesis genes, while increasing the lipid droplet content and TM6SF2 overexpression increased lipid droplets [41]. This evidence concerns the gene TM6SF2 and hepatocellular carcinoma.